ost mental health disorders are polygenic, 1,2 in that their genetic influences involve thousands of DNA variants, nearly all of which have very small influences. Polygenic risk scores (PRS) provide an estimate of the degree to which an individual is at risk for a given illness because of their genetic makeup, calculated from identified polygenic contributions of risk. This review is preceded by a companion primer article 3 that provides a baseline discussion of PRS (Figure 1) and examples of applications of PRS in other branches of medicine. More nuanced interpretations may be demanded by application to common mental health disorders. Polygenic risk scores can be measured for a wide range of diseases and disorders from a single saliva or blood sample, using inexpensive genotyping technologies (<$100 per person). Moreover, the return of PRS to patients is already undergoing research trials in health systems around the world. Although the primary motivation for such trials lies with risk for physical health disorders, applications to mental health disorders are also being investigated. 4 We argue in our previously published related primer 3 that PRS should be viewed similarly to many tests used in health care (such as tests of lipid levels and lipoprotein biomarker concentrations for the assessment of coronary artery disease 5 ); despite limited prog-nosticative accuracy, they still might be able to make a useful clinical contribution in some settings. Imperfect predictive accuracy of PRS is expected, because genetic factors are not the only risk factors for common disorders and the risk scores can only provide data about part of the genetic contribution. In the primer, 3 we have discussed factors that contribute to the accuracy with which risk variants and their weights are estimated (including that predictive accuracy is currently lower in those of non-European ancestry) and considered how PRS could be used in different community or clinical settings. In this review, we evaluate these scenarios (Figure 2) in the context of psychiatry.How Useful Are Psychiatric PRS Now and in the Future? Polygenic risk scores for schizophrenia and major depression have been evaluated in Psychiatric Genomics Consortium articles, [6][7][8] health care settings, 9,10 and a randomly ascertained sample from the Danish general population. [11][12][13][14] We focus on schizophrenia and major depression because, to date, the data sets used to identify these risk variants are the largest. Also, given that schizophrenia affects IMPORTANCE Polygenic risk scores (PRS) are predictors of the genetic susceptibility to diseases, calculated for individuals as weighted counts of thousands of risk variants in which the risk variants and their weights have been identified in genome-wide association studies. Polygenic risk scores show promise in aiding clinical decision-making in many areas of medical practice. This review evaluates the potential use of PRS in psychiatry.OBSERVATIONS On their own, PRS will never be able to establish or definitivel...